On August 30, 2023 ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, reported that management will participate in the following investor conferences in the first half of September (Press release, ORIC Pharmaceuticals, AUG 30, 2023, View Source [SID1234634774]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Citi’s 2023 18th Annual BioPharma Conference – Participating in a targeted oncology panel on Wednesday, September 6, 2023, at 1:00 p.m. ET

Wells Fargo 2023 Healthcare Conference – Participating in a fireside chat on Thursday, September 7, 2023, at 11:00 a.m. ET

H.C. Wainwright 25th Annual Global Investment Conference – Presenting company overview on Monday, September 11, 2023, at 12:30 p.m. ET

Baird 2023 Global Healthcare Conference – Participating in a fireside chat on Tuesday, September 12, 2023, at 2:35 p.m. ET
Webcasts of the panel discussion and presentations will be available through the investor section of the company’s website at www.oricpharma.com. Replays of webcasts will be available for 90 days following the events.